Trials / Sponsors / Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)

Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)

Industry · 6 registered clinical trials.

Status	Trial	Phase	Started
Completed	Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers Healthy	Phase 1	2018-05-01
Completed	A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Gram-Negative Bacterial Infections	—	2017-10-11
Terminated	Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficien Renal Insufficiency, Acute, Renal Insufficiency, Chronic, Healthy Subjects	Phase 1	2017-05-29
Completed	Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Normal Healthy Volunteers	Phase 1	2017-04-20
Completed	Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections i Urinary Tract Infection Complicated, Acute Pyelonephritis, Hospital Acquired Bacterial Pneumonia	Phase 3	2014-07-01
Completed	Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae Urinary Tract Infection, Complicated, Acute Pyelonephritis, Hospital Acquired Bacterial Pneumonia	—	2014-05-01